These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1335 related items for PubMed ID: 17082219
1. A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months. Akakura K, Suzuki H, Ichikawa T, Fujimoto H, Maeda O, Usami M, Hirano D, Takimoto Y, Kamoto T, Ogawa O, Sumiyoshi Y, Shimazaki J, Kakizoe T, Japanese Study Group for Locally Advanced Prostate Cancer. Jpn J Clin Oncol; 2006 Dec; 36(12):789-93. PubMed ID: 17082219 [Abstract] [Full Text] [Related]
2. Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities. Akakura K, Isaka S, Akimoto S, Ito H, Okada K, Hachiya T, Yoshida O, Arai Y, Usami M, Kotake T, Tobisu K, Ohashi Y, Sumiyoshi Y, Kakizoe T, Shimazaki J. Urology; 1999 Aug; 54(2):313-8. PubMed ID: 10443731 [Abstract] [Full Text] [Related]
3. Long-term followup of a randomized study of locally advanced prostate cancer treated with combined orchiectomy and external radiotherapy versus radiotherapy alone. Granfors T, Modig H, Damber JE, Tomic R. J Urol; 2006 Aug; 176(2):544-7. PubMed ID: 16813885 [Abstract] [Full Text] [Related]
4. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation. Demanes DJ, Brandt D, Schour L, Hill DR. Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902 [Abstract] [Full Text] [Related]
12. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P. Eur Urol; 2009 May 15; 55(5):1003-11. PubMed ID: 19211184 [Abstract] [Full Text] [Related]
13. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer. Jo Y, Hiratsuka J, Fujii T, Takenaka A, Fujisawa M. Urology; 2004 Sep 15; 64(3):556-60. PubMed ID: 15351592 [Abstract] [Full Text] [Related]
14. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. Bolla M, Gonzalez D, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Gil T, Collette L, Pierart M. N Engl J Med; 1997 Jul 31; 337(5):295-300. PubMed ID: 9233866 [Abstract] [Full Text] [Related]
15. Surgery versus implant for early prostate cancer: results from a single institution, 1992-2005. Colberg JW, Decker RH, Khan AM, McKeon A, Wilson LD, Peschel RE. Cancer J; 2007 Jul 31; 13(4):229-32. PubMed ID: 17762756 [Abstract] [Full Text] [Related]
16. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy. Mayer FJ, Crawford ED. Urol Clin North Am; 1994 Nov 31; 21(4):707-15. PubMed ID: 7974899 [Abstract] [Full Text] [Related]